Cite
MLA Citation
S M de Boer et al.. “Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer.” Annals of oncology, vol. 29, 2018, pp. 424–430. http://access.bl.uk/ark:/81055/vdc_100097078710.0x00002e